Shattuck Labs (STTK) Net Margin (2019 - 2025)
Shattuck Labs (STTK) posted quarterly Net Margin of 1111.6% for Q3 2025, down 48698.0% year-over-year from N/an in Q3 2024, and down 77.96% quarter-over-quarter from 624.62% in Q3 2024.
Shattuck Labs (STTK) Net Margin (2019 - 2025) Analysis & Trends
Shattuck Labs (STTK) has reported Net Margin for 7 consecutive years, with 1111.6% the latest figure, recorded in Q3 2025.
- In Q3 2025, Net Margin fell 48698.0% year-over-year to 1111.6%; the TTM figure through Mar 2026 stood at 15907.1% (down 1217403.0% YoY), while the FY2025 annual figure was 15549.1%, down 1255985.0% from the prior year.
- Net Margin retreated to 1111.6% in Q3 2025 per STTK's latest filing, from 624.62% in the prior quarter.
- Across five years, Net Margin topped out at 74.8% in Q4 2021 and bottomed at 58290.0% in Q2 2022.
- Historically, Net Margin has averaged 10556.2% across 5 years, with a median of 2909.78% in 2024.
- Annual changes were most pronounced in 2022 — Net Margin tumbled 5711978 bps — and 2023, when it surged 4676650 bps.
- Shattuck Labs' Net Margin stood at 74.8% in 2021, then plunged by 8839 bps to 6686.15% in 2022, then tumbled by 100 bps to 13352.52% in 2023, then soared by 95 bps to 624.62% in 2024, then sank by 78 bps to 1111.6% in 2025.
- Business Quant data shows STTK's Net Margin at 1111.6% in Q3 2025, 624.62% in Q3 2024, and 1507.89% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,111.60% |
| Sep 30, 2024 | -624.62% |
| Jun 30, 2024 | -1,507.89% |
| Mar 31, 2024 | -2,909.78% |
| Dec 31, 2023 | -13,352.52% |
| Sep 30, 2023 | -4,183.38% |
| Jun 30, 2023 | -11,523.50% |
| Mar 31, 2023 | -38,352.63% |
| Dec 31, 2022 | -6,686.15% |
| Sep 30, 2022 | -14,939.62% |
| Jun 30, 2022 | -58,290.00% |
| Dec 31, 2021 | -74.80% |
| Sep 30, 2021 | -1,927.84% |
| Jun 30, 2021 | -1,170.22% |
| Mar 31, 2021 | -1,688.41% |
| Dec 31, 2020 | -2,177.42% |
| Sep 30, 2020 | -831.75% |
| Jun 30, 2020 | -194.34% |
| Mar 31, 2020 | -218.78% |
| Dec 31, 2019 | -552.11% |